FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204177860> ?p ?o ?g. }

• W3204177860 endingPage "398" @default.
• W3204177860 startingPage "388" @default.
• W3204177860 abstract "Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for relapsed or refractory large B-cell lymphoma (R/R LBCL). To reduce axi-cel–related toxicity, several exploratory safety management cohorts were added to ZUMA-1 (NCT02348216), the pivotal phase 1/2 study of axi-cel in refractory LBCL. Cohort 4 evaluated the rates and severity of cytokine release syndrome (CRS) and neurologic events (NEs) with earlier corticosteroid and tocilizumab use. Primary endpoints were incidence and severity of CRS and NEs. Patients received 2 × 106 anti-CD19 CAR T cells/kg after conditioning chemotherapy. Forty-one patients received axi-cel. Incidences of any-grade CRS and NEs were 93% and 61%, respectively (grade ≥ 3, 2% and 17%). There was no grade 4 or 5 CRS or NE. Despite earlier dosing, the cumulative cortisone-equivalent corticosteroid dose in patients requiring corticosteroid therapy was lower than that reported in the pivotal ZUMA-1 cohorts. With a median follow-up of 14·8 months, objective and complete response rates were 73% and 51%, respectively, and 51% of treated patients were in ongoing response. Earlier and measured use of corticosteroids and/or tocilizumab has the potential to reduce the incidence of grade ≥ 3 CRS and NEs in patients with R/R LBCL receiving axi-cel." @default.
• W3204177860 created "2021-10-11" @default.
• W3204177860 creator A5015194203 @default.
• W3204177860 creator A5026220374 @default.
• W3204177860 creator A5027885217 @default.
• W3204177860 creator A5029619751 @default.
• W3204177860 creator A5031216970 @default.
• W3204177860 creator A5032917190 @default.
• W3204177860 creator A5033073385 @default.
• W3204177860 creator A5034434819 @default.
• W3204177860 creator A5036293139 @default.
• W3204177860 creator A5041057399 @default.
• W3204177860 creator A5043125083 @default.
• W3204177860 creator A5049413660 @default.
• W3204177860 creator A5064185471 @default.
• W3204177860 creator A5064789111 @default.
• W3204177860 creator A5068452218 @default.
• W3204177860 creator A5069105295 @default.
• W3204177860 creator A5070180314 @default.
• W3204177860 creator A5079688295 @default.
• W3204177860 creator A5083858828 @default.
• W3204177860 creator A5085255418 @default.
• W3204177860 creator A5086115833 @default.
• W3204177860 creator A5091739351 @default.
• W3204177860 date "2021-09-29" @default.
• W3204177860 modified "2023-10-16" @default.
• W3204177860 title "Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma" @default.
• W3204177860 cites W1964475341 @default.
• W3204177860 cites W2036193982 @default.
• W3204177860 cites W2082708772 @default.
• W3204177860 cites W2099570622 @default.
• W3204177860 cites W2143416241 @default.
• W3204177860 cites W2150291618 @default.
• W3204177860 cites W2340435799 @default.
• W3204177860 cites W2564064015 @default.
• W3204177860 cites W2763751953 @default.
• W3204177860 cites W2773804840 @default.
• W3204177860 cites W2790064422 @default.
• W3204177860 cites W2792798899 @default.
• W3204177860 cites W2892365723 @default.
• W3204177860 cites W2901133714 @default.
• W3204177860 cites W2901262057 @default.
• W3204177860 cites W2903225254 @default.
• W3204177860 cites W2904964912 @default.
• W3204177860 cites W2942621614 @default.
• W3204177860 cites W2944998775 @default.
• W3204177860 cites W2980542859 @default.
• W3204177860 cites W2991566266 @default.
• W3204177860 cites W2998859344 @default.
• W3204177860 cites W3004644443 @default.
• W3204177860 cites W3024978145 @default.
• W3204177860 cites W3032210049 @default.
• W3204177860 cites W3044532926 @default.
• W3204177860 cites W3087057425 @default.
• W3204177860 cites W3092023747 @default.
• W3204177860 cites W3097517620 @default.
• W3204177860 cites W3128956257 @default.
• W3204177860 doi "https://doi.org/10.1111/bjh.17673" @default.
• W3204177860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34590303" @default.
• W3204177860 hasPublicationYear "2021" @default.
• W3204177860 type Work @default.
• W3204177860 sameAs 3204177860 @default.
• W3204177860 citedByCount "34" @default.
• W3204177860 countsByYear W32041778602022 @default.
• W3204177860 countsByYear W32041778602023 @default.
• W3204177860 crossrefType "journal-article" @default.
• W3204177860 hasAuthorship W3204177860A5015194203 @default.
• W3204177860 hasAuthorship W3204177860A5026220374 @default.
• W3204177860 hasAuthorship W3204177860A5027885217 @default.
• W3204177860 hasAuthorship W3204177860A5029619751 @default.
• W3204177860 hasAuthorship W3204177860A5031216970 @default.
• W3204177860 hasAuthorship W3204177860A5032917190 @default.
• W3204177860 hasAuthorship W3204177860A5033073385 @default.
• W3204177860 hasAuthorship W3204177860A5034434819 @default.
• W3204177860 hasAuthorship W3204177860A5036293139 @default.
• W3204177860 hasAuthorship W3204177860A5041057399 @default.
• W3204177860 hasAuthorship W3204177860A5043125083 @default.
• W3204177860 hasAuthorship W3204177860A5049413660 @default.
• W3204177860 hasAuthorship W3204177860A5064185471 @default.
• W3204177860 hasAuthorship W3204177860A5064789111 @default.
• W3204177860 hasAuthorship W3204177860A5068452218 @default.
• W3204177860 hasAuthorship W3204177860A5069105295 @default.
• W3204177860 hasAuthorship W3204177860A5070180314 @default.
• W3204177860 hasAuthorship W3204177860A5079688295 @default.
• W3204177860 hasAuthorship W3204177860A5083858828 @default.
• W3204177860 hasAuthorship W3204177860A5085255418 @default.
• W3204177860 hasAuthorship W3204177860A5086115833 @default.
• W3204177860 hasAuthorship W3204177860A5091739351 @default.
• W3204177860 hasBestOaLocation W32041778602 @default.
• W3204177860 hasConcept C121608353 @default.
• W3204177860 hasConcept C126322002 @default.
• W3204177860 hasConcept C141071460 @default.
• W3204177860 hasConcept C197934379 @default.
• W3204177860 hasConcept C2776804153 @default.
• W3204177860 hasConcept C2777178219 @default.
• W3204177860 hasConcept C2777575956 @default.
• W3204177860 hasConcept C2777701055 @default.
• W3204177860 hasConcept C2779338263 @default.

• next